Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro
M. Hein, S. Zeck, M. Krug, J. Meißner-Weigl, O. Bahr, K. Kriukov, M. Kuric, D. Docheva, M. Rudert, K. Horas, R. Ebert · 2026
Read Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro by M. Hein, S. Zeck, M. Krug, J. Meißner-Weigl, O. Bahr, K. Kriukov, M. Kuric, D. Docheva, M. Rudert, K. Horas, R. Ebert (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13470584.txt.
Description
Hein and colleagues report a 2026 laboratory study of vitamin D's active form against primary malignant bone tumors, rare cancers of bone itself. Low vitamin D levels have been linked to these tumors' occurrence. The team exposed four tumor cell lines, covering osteosarcoma, chondrosarcoma, and Ewing sarcoma, to the active hormone and measured growth, death, movement, and vitamin D machinery.
The active hormone engaged its receptor in the tumor cells, moving it into the nucleus where it switches genes. Treated cells grew less and invaded less in the assays, . Enzymes that make and break down the hormone were also profiled, since tumors can tune their own exposure. Cell results cannot promise patient benefit, but they justify testing vitamin D pathways as an add-on in tumors with few options.
Catalog record
| CREATOR | M. Hein, S. Zeck, M. Krug, J. Meißner-Weigl, O. Bahr, K. Kriukov, M. Kuric, D. Docheva, M. Rudert, K. Horas, R. Ebert |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |